We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

87 hedge funds and large institutions have $650M invested in GW Pharmaceuticals Plc American Depositary Shares in 2014 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 87 → 87 (0)

0% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 26

19% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 26

25% less call options, than puts

Call options by funds: $35.4M | Put options by funds: $47M

26% less capital invested

Capital invested by funds: $884M → $650M (-$234M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
87
Holders Change
–
Holders Change %
0%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
26
Increased
21
Reduced
26
Closed
26
Calls
$35.4M
Puts
$47M
Net Calls
-$11.6M
Net Calls Change
-$6.17M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$19.6M
2
CCP
Clough Capital Partners
Massachusetts
+$17M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$16.5M
4
Capital Research Global Investors
Capital Research Global Investors
California
+$16.4M
5
CCM
Cupps Capital Management
Illinois
+$8.87M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$21.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.6M
3
Franklin Resources
Franklin Resources
California
-$18.9M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$15.6M
5
FCM
Farallon Capital Management
California
-$9.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
76
Hudock Inc
Pennsylvania
$12K +$2.65K +30 +25%
FFC
77
First Financial Corp
Indiana
$11K – – –
MFS
78
MSI Financial Services
Massachusetts
$10K -$4.42K -50 -29%
Barclays
79
Barclays
United Kingdom
$9K +$10.4K +118 New
Bessemer Group
80
Bessemer Group
New Jersey
$8K – – –
MSFP
81
Mark Sheptoff Financial Planning
Connecticut
$8K – – –
VIA
82
Vantage Investment Advisors
Pennsylvania
$8K – – –
PMFA
83
Plante Moran Financial Advisors
Michigan
$8K +$8.32K +94 New
ARMC
84
American Research & Management Company
Massachusetts
$4K – – –
WA
85
WFG Advisors
Texas
$4K – – –
MCM
86
Manchester Capital Management
Vermont
$3K – – –
Jennison Associates
87
Jennison Associates
New York
– -$21.4M -199,316 Closed
T. Rowe Price Associates
88
T. Rowe Price Associates
Maryland
– -$15.6M -145,724 Closed
MGM
89
Miura Global Management
New York
– -$7.51M -70,000 Closed
MHP
90
Manatuck Hill Partners
Connecticut
– -$6.32M -58,900 Closed
Lord, Abbett & Co
91
Lord, Abbett & Co
New Jersey
– -$5.04M -46,959 Closed
LCM
92
Laurion Capital Management
New York
– -$4.3M -40,100 Closed
DM
93
Deerfield Management
New York
– -$4.29M -40,000 Closed
GACM
94
Green Arrow Capital Management
New York
– -$4.29M -40,000 Closed
HCMT
95
Highland Capital Management (Texas)
Texas
– -$3.71M -34,611 Closed
SGH
96
Schonfeld Group Holdings
New York
– -$2.01M -18,700 Closed
PCA
97
Private Capital Advisors
Connecticut
– -$1.79M -16,700 Closed
GA
98
Geneva Advisors
Illinois
– -$696K -6,485 Closed
ICAS
99
Investors Capital Advisory Services
Massachusetts
– -$650K -6,061 Closed
CSS
100
Cubist Systematic Strategies
Connecticut
– -$496K -4,619 Closed
1 2 3
4
5

GWPH Hedge Fund Activity: Q3 2014 in Review

87 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2014, worth a combined $650M — down 26% from $884M a quarter earlier.

Fund positioning in GWPH was balanced in Q3 2014: 26 funds opened new positions, 26 closed out, 21 added to existing stakes and 26 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $19.6M. The largest seller was Jennison Associates, exiting entirely with an estimated $21.4M sold.

  • 87 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $650M of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2014, down 26% quarter-over-quarter.
  • 26 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2014 and 26 closed out, a net change of 0 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2014 was OrbiMed, an estimated $19.6M added.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2014 was Jennison Associates, an estimated $21.4M sold.

Based on aggregated 13F filings for Q3 2014.